Showing 941-950 of 3019 results for "".
ASLMS New Beginnings Initiative
https://practicaldermatology.com/programs/practical-dermatology/aslms-new-beginnings-initiative/18188/In 2014, the American Society for Laser Medicine and Surgery started its New Beginnings initiative. Initially launched to benefit cancer survivors, ASLMS physicians volunteered to remove radiation tattoos pro bono. Recently, the ASLMS, under the leadership of its president Paul Friedman, MD, expandeA New Era in Plaque Psoriasis Care: Examining Topical Nonsteroidal Therapies
https://practicaldermatology.com/programs/dermconsult/a-new-era-in-plaque-psoriasis-care-examining-topical-nonsteroidal-therapies/15834/What are the benefits of using topical nonsteroidals for patients with plaque psoriasis? Join us to find out.Pediatric Psoriasis: Clinical Presentation and Topical Treatment Strategies
https://practicaldermatology.com/programs/frontlines-psoriasis/pediatric-psoriasis-clinical-presentation-and-topical-treatment-strategies/26300/Learn about the clinical presentation of pediatric psoriasis and how we can treat our youngest patients with topical treatments.Unveiling the Latest Advancements in CKD-Associated Pruritus Care
https://practicaldermatology.com/programs/cme/unveiling-the-latest-advancements-in-ckd-associated-pruritus-care/26636/Keep up with the newest real-world data and clinical results of difelikefalin presented at ERA, including the Andalusia and CENSUS-EU studies.Weighing the Role of Network Meta-analysis for Choosing Biologic Therapies in Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/weighing-the-role-of-network-meta-analysis-for-choosing-biologic-therapies-in-psoriatic-disease/18189/There’s no paucity of studies for biologic therapies used to treat psoriatic disease, but the number of head-to-head trials comparing these agents is limited. Enter network meta-analysis, a statistical methodology that has emerged over the past few years to compare medication. Philip Mease, MD, a clStudy: Psoriasis Patients with Skin of Color Wait 3x Longer for Diagnosis
https://practicaldermatology.com/programs/frontlines-psoriasis/study-psoriasis-patients-with-skin-of-color-wait-3x-longer-for-diagnosis/24376/Dive into the findings from a recent study that investigated racial disparities in the diagnosis and treatment of psoriasis.A Biologic Test for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-biologic-test-for-cutaneous-squamous-cell-carcinoma/24025/Cutaneous squamous cell carcinoma (cSCC) encompasses a broad spectrum of disease severity, from superficial and easily treatable skin lesions to potentially life-threatening metastatic cancer. Adjuvant radiation therapy (ART) is recommended to reduce the likelihood of relapse following surgical reseDermWireTV: Updates from ASDS: EBDs, Injectables, Scars, DEI
https://practicaldermatology.com/topics/practice-management/dermwiretv-updates-from-asds-ebds-injectables-scars-dei/20029/The annual meeting of the American Society for Dermatology Surgery (ASDS) brings together top dermatologists to share their expertise. This year’s virtual meeting offered a look at a range of new and emerging treatments and some updates on existing options, including insights from Jeanine B. Downie,Hair Care Trends You Need to Know
https://practicaldermatology.com/conferences/aad-summer-2021/hair-care-trends-you-need-to-know/19976/People are sharing more than their latest dance moves on TikTok. Many—with no background in science—are dispensing hair care advice, some of which could even be dangerous. Learn which trends you should know about in order to educate your patients about what really works versus what could do more harDermWireTV: Pulse's CellFX, Soliton's RAP Technology, Belotero Balance (+), Restylane Defyne, Eczema Costs
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pulses-cellfx-solitons-rap-technology-belotero-balance-restylane-defyne-eczema-costs/19899/The FDA has cleared Pulse Biosciences’ CellFX system, and a commercial rollout will begin soon. There’s another new option for treatment for legs with FDA clearance of Soliton’s Rapid Acoustic Pulse technology for cellulite. For eight percent of Americans with atopic dermatitis, annual out of pocket